As of 2024-07-27, the EV/EBITDA ratio of AtriCure Inc (ATRC) is -111.94. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. AtriCure's latest enterprise value is 1,026.20 mil USD. AtriCure's TTM EBITDA according to its financial statements is -9.17 mil USD. Dividing these 2 quantities gives us the above AtriCure EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.4x - 18.9x | 16.6x |
| Forward P/E multiples | 15.3x - 31.2x | 22.6x |
| Fair Price | (2.01) - (2.68) | (2.82) |
| Upside | -109.1% - -112.1% | -112.7% |
| Date | EV/EBITDA |
| 2024-07-26 | -111.94 |
| 2024-07-25 | -119.49 |
| 2024-07-24 | -121.92 |
| 2024-07-23 | -125.82 |
| 2024-07-22 | -121.02 |
| 2024-07-19 | -122.87 |
| 2024-07-18 | -125.51 |
| 2024-07-17 | -127.62 |
| 2024-07-16 | -128.83 |
| 2024-07-15 | -120.81 |
| 2024-07-12 | -117.70 |
| 2024-07-11 | -118.75 |
| 2024-07-10 | -112.42 |
| 2024-07-09 | -112.68 |
| 2024-07-08 | -110.57 |
| 2024-07-05 | -120.23 |
| 2024-07-03 | -113.79 |
| 2024-07-02 | -113.48 |
| 2024-07-01 | -114.06 |
| 2024-06-28 | -115.48 |
| 2024-06-27 | -118.23 |
| 2024-06-26 | -116.69 |
| 2024-06-25 | -107.62 |
| 2024-06-24 | -111.58 |
| 2024-06-21 | -116.38 |
| 2024-06-20 | -120.73 |
| 2024-06-18 | -107.19 |
| 2024-06-17 | -100.12 |
| 2024-06-14 | -104.87 |
| 2024-06-13 | -105.98 |
| 2024-06-12 | -111.73 |
| 2024-06-11 | -110.99 |
| 2024-06-10 | -110.63 |
| 2024-06-07 | -113.63 |
| 2024-06-06 | -114.48 |
| 2024-06-05 | -112.47 |
| 2024-06-04 | -114.11 |
| 2024-06-03 | -113.63 |
| 2024-05-31 | -114.27 |
| 2024-05-30 | -112.79 |
| 2024-05-29 | -109.36 |
| 2024-05-28 | -114.95 |
| 2024-05-24 | -117.70 |
| 2024-05-23 | -113.84 |
| 2024-05-22 | -115.32 |
| 2024-05-21 | -113.79 |
| 2024-05-20 | -113.05 |
| 2024-05-17 | -117.43 |
| 2024-05-16 | -114.74 |
| 2024-05-15 | -112.05 |